• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Angiogenesis and melanoma.血管生成与黑色素瘤。
Cancers (Basel). 2010 Feb 25;2(1):114-32. doi: 10.3390/cancers2010114.
2
Angiogenesis and anti-angiogenesis in neuroblastoma.神经母细胞瘤中的血管生成与抗血管生成
Eur J Cancer. 2002 Apr;38(6):750-7. doi: 10.1016/s0959-8049(01)00337-9.
3
Angiogenesis in neuroblastoma.神经母细胞瘤中的血管生成
Ann N Y Acad Sci. 2004 Dec;1028:133-42. doi: 10.1196/annals.1322.014.
4
The role of the vascular phase in solid tumor growth: a historical review.血管期在实体瘤生长中的作用:历史回顾
Neoplasia. 1999 Oct;1(4):293-302. doi: 10.1038/sj.neo.7900038.
5
[Angiogenesis and tumor progression in melanoma].[黑色素瘤中的血管生成与肿瘤进展]
Recenti Prog Med. 2000 Nov;91(11):581-7.
6
[Angiogenesis and anti-angiogenesis in human neoplasms. Recent developments and the therapeutic prospects].[人类肿瘤中的血管生成与抗血管生成。最新进展与治疗前景]
Ann Ital Med Int. 2000 Jan-Mar;15(1):7-19.
7
Vascular endothelial growth factor and its receptors in multiple myeloma.血管内皮生长因子及其受体在多发性骨髓瘤中的作用
Leukemia. 2003 Oct;17(10):1961-6. doi: 10.1038/sj.leu.2403076.
8
Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor.癌症治疗中针对血管生成:超越血管内皮生长因子
Oncologist. 2015 Jun;20(6):660-73. doi: 10.1634/theoncologist.2014-0465. Epub 2015 May 22.
9
Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy.血管内皮细胞生长因子(VEGF),一种新兴的癌症化疗靶点。
Curr Med Chem Anticancer Agents. 2003 Mar;3(2):95-117. doi: 10.2174/1568011033353452.
10
Angiogenesis and progression in human melanoma.人类黑色素瘤中的血管生成与进展
Dermatol Res Pract. 2010;2010:185687. doi: 10.1155/2010/185687. Epub 2010 Jun 6.

引用本文的文献

1
Molecular Imaging of Melanoma VEGF-expressing Tumors through [Tc]Tc-HYNIC-Fab(Bevacizumab).通过[锝]Tc-HYNIC-Fab(贝伐单抗)对表达黑色素瘤血管内皮生长因子的肿瘤进行分子成像。
Anticancer Agents Med Chem. 2024;24(18):1347-1359. doi: 10.2174/0118715206294297240805073550.
2
Angiogenesis Still Plays a Crucial Role in Human Melanoma Progression.血管生成在人类黑色素瘤进展中仍起着关键作用。
Cancers (Basel). 2024 May 8;16(10):1794. doi: 10.3390/cancers16101794.
3
WNT5A-ROR2 axis mediates VEGF dependence of BRAF mutant melanoma.WNT5A-ROR2 轴介导 BRAF 突变型黑色素瘤对 VEGF 的依赖性。
Cell Oncol (Dordr). 2023 Apr;46(2):391-407. doi: 10.1007/s13402-022-00757-7. Epub 2022 Dec 21.
4
In vivo multimodal optical imaging of dermoscopic equivocal melanocytic skin lesions.皮肤镜下可疑黑素细胞皮肤病变的体内多模态光学成像。
Sci Rep. 2021 Jan 14;11(1):1405. doi: 10.1038/s41598-020-80744-w.
5
Multi-Omics and Informatics Analysis of FFPE Tissues Derived from Melanoma Patients with Long/Short Responses to Anti-PD1 Therapy Reveals Pathways of Response.对接受抗PD1治疗有长/短反应的黑色素瘤患者的FFPE组织进行多组学和信息学分析揭示了反应途径。
Cancers (Basel). 2020 Nov 26;12(12):3515. doi: 10.3390/cancers12123515.
6
Prognostic biomarkers for immunotherapy with ipilimumab in metastatic melanoma.免疫检查点抑制剂伊匹单抗治疗转移性黑色素瘤的预后生物标志物。
Clin Exp Immunol. 2019 Jul;197(1):74-82. doi: 10.1111/cei.13283. Epub 2019 Mar 21.
7
Surgical management of tumor-positive interval node in melanoma patients: An observational study.黑色素瘤患者肿瘤阳性间期淋巴结的外科治疗:一项观察性研究。
Medicine (Baltimore). 2018 May;97(18):e0584. doi: 10.1097/MD.0000000000010584.
8
An Improved Methodology to Visualise Tumour Induced Changes in Vasculature Using the Chick Chorionic Allantoic Membrane Assay.一种利用鸡胚绒毛尿囊膜试验可视化肿瘤诱导的血管变化的改进方法。
In Vivo. 2018 May-Jun;32(3):461-472. doi: 10.21873/invivo.11262.
9
Recanalization and remodeling of the great saphenous vein caused by the large melanoma's cutaneous metastasis.大黑色素瘤皮肤转移导致大隐静脉再通和重塑。
Contemp Oncol (Pozn). 2018;22(1):54-59. doi: 10.5114/wo.2018.74396. Epub 2018 Apr 3.
10
Metastatic pathway and the microvascular and physicochemical microenvironments of human melanoma xenografts.人黑色素瘤异种移植物的转移途径和微血管及理化微环境。
J Transl Med. 2017 Oct 10;15(1):203. doi: 10.1186/s12967-017-1307-4.

本文引用的文献

1
Inhibition of angiotensin II receptor 1 limits tumor-associated angiogenesis and attenuates growth of murine melanoma.血管紧张素 II 受体 1 抑制剂限制肿瘤相关血管生成并减弱小鼠黑色素瘤的生长。
Cancer Chemother Pharmacol. 2010 May;66(1):79-87. doi: 10.1007/s00280-009-1136-0. Epub 2009 Sep 22.
2
Results of a multicenter, randomized, double-blind, dose-evaluating phase 2/3 study of lenalidomide in the treatment of metastatic malignant melanoma.来那度胺治疗转移性恶性黑色素瘤的多中心、随机、双盲、剂量评估2/3期研究结果
Cancer. 2009 Nov 15;115(22):5228-36. doi: 10.1002/cncr.24576.
3
Crosstalk between protease-activated receptor 1 and platelet-activating factor receptor regulates melanoma cell adhesion molecule (MCAM/MUC18) expression and melanoma metastasis.蛋白酶激活受体1与血小板活化因子受体之间的相互作用调节黑色素瘤细胞粘附分子(MCAM/MUC18)的表达及黑色素瘤转移。
J Biol Chem. 2009 Oct 16;284(42):28845-55. doi: 10.1074/jbc.M109.042150. Epub 2009 Aug 24.
4
The implication of platelet activating factor in cancer growth and metastasis: potent beneficial role of PAF-inhibitors and antioxidants.血小板活化因子在癌症生长和转移中的作用:PAF抑制剂和抗氧化剂的强大有益作用
Infect Disord Drug Targets. 2009 Aug;9(4):390-9. doi: 10.2174/187152609788922555.
5
Functional activity of CXCL8 receptors, CXCR1 and CXCR2, on human malignant melanoma progression.CXCL8受体CXCR1和CXCR2的功能活性对人类恶性黑色素瘤进展的影响
Eur J Cancer. 2009 Sep;45(14):2618-27. doi: 10.1016/j.ejca.2009.07.007. Epub 2009 Aug 13.
6
Platelet-derived growth factor-receptor alpha strongly inhibits melanoma growth in vitro and in vivo.血小板衍生生长因子受体α在体外和体内均能强烈抑制黑色素瘤的生长。
Neoplasia. 2009 Aug;11(8):732-42. doi: 10.1593/neo.09408.
7
Immune cells and angiogenesis.免疫细胞与血管生成。
J Cell Mol Med. 2009 Sep;13(9A):2822-33. doi: 10.1111/j.1582-4934.2009.00810.x. Epub 2009 Jun 16.
8
Phase II trial of dacarbazine and thalidomide for the treatment of metastatic melanoma.达卡巴嗪与沙利度胺治疗转移性黑色素瘤的II期试验
Chemotherapy. 2009;55(4):221-7. doi: 10.1159/000219435. Epub 2009 May 19.
9
CXCR1 and CXCR2 enhances human melanoma tumourigenesis, growth and invasion.CXCR1和CXCR2可增强人类黑色素瘤的肿瘤发生、生长和侵袭。
Br J Cancer. 2009 May 19;100(10):1638-46. doi: 10.1038/sj.bjc.6605055. Epub 2009 Apr 28.
10
Inflammation and melanoma metastasis.炎症与黑色素瘤转移
Pigment Cell Melanoma Res. 2009 Jun;22(3):257-67. doi: 10.1111/j.1755-148X.2009.00570.x. Epub 2009 Apr 8.

血管生成与黑色素瘤。

Angiogenesis and melanoma.

机构信息

Department of Human Anatomy and Histology, University of Bari Medical School, Piazza G. Cesare, 11, Policlinico 70124, Bari, Italy.

出版信息

Cancers (Basel). 2010 Feb 25;2(1):114-32. doi: 10.3390/cancers2010114.

DOI:10.3390/cancers2010114
PMID:24281035
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3827594/
Abstract

Angiogenesis occurs in pathological conditions, such as tumors, where a specific critical point in tumor progression is the transition from the avascular to the vascular phase. Tumor angiogenesis depends mainly on the release by neoplastic cells of growth factors specific for endothelial cells, which are able to stimulate the growth of the host's blood vessels. This article summarizes the literature concerning the relationship between angiogenesis and human melanoma progression. The recent applications of antiangiogenic agents which interfere with melanoma progression are also described.

摘要

血管生成发生在病理条件下,如肿瘤,其中肿瘤进展的一个特定关键点是从无血管到血管阶段的转变。肿瘤血管生成主要取决于肿瘤细胞释放特定于内皮细胞的生长因子,这些生长因子能够刺激宿主血管的生长。本文总结了有关血管生成与人类黑色素瘤进展之间关系的文献。还描述了最近应用抗血管生成药物来干扰黑色素瘤进展的情况。